Is bivalirudin ready for a comeback? Pros and cons

EuroIntervention. 2024 Aug 5;20(15):e912-e914. doi: 10.4244/EIJ-E-24-00013.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antithrombins* / therapeutic use
  • Hirudins*
  • Humans
  • Peptide Fragments* / therapeutic use
  • Percutaneous Coronary Intervention / methods
  • Recombinant Proteins* / therapeutic use
  • Treatment Outcome

Substances

  • bivalirudin
  • Hirudins
  • Recombinant Proteins
  • Peptide Fragments
  • Antithrombins